 | • レポートコード：MRC2304A110 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、223ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社は、2021年に6,791.22百万ドルであった世界の神経調節デバイス市場規模が2022年に7,665.26百万ドルに到達し、2027年までにCAGR 13.12％で成長して14,233.08百万ドルへと拡大すると予測しています。当調査資料では、神経調節デバイスの世界市場について多角的な視点から分析を行い、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品タイプ別（脳深部刺激装置、仙骨神経刺激装置、脊髄刺激装置、経頭蓋磁気刺激装置、迷走神経刺激装置）分析、用途別（神経疾患、疼痛管理、呼吸器疾患）分析、エンドユーザー別（病院、専門クリニック＆外来センター）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの項目をまとめました。なお、当書内の企業情報としては、Abbott Laboratories、Aleva Neurotherapeutics SA、Avanos Medical Inc、Axonics Modulation Technologies Inc、B. Braun Melsungen AG、Beijing Pins Medical Co Ltd、Bioness Neuromodulation Ltd.、Boston Scientific Corporation、iNano Medical inc.などが掲載されています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の神経調節デバイス市場規模：製品タイプ別 - 脳深部刺激装置の市場規模 - 仙骨神経刺激装置の市場規模 - 脊髄刺激装置の市場規模 - 経頭蓋磁気刺激装置の市場規模 - 迷走神経刺激装置の市場規模 ・世界の神経調節デバイス市場規模：用途別 - 神経疾患における市場規模 - 疼痛管理における市場規模 - 呼吸器疾患における市場規模 ・世界の神経調節デバイス市場規模：エンドユーザー別 - 病院における市場規模 - 専門クリニック＆外来センターにおける市場規模 ・世界の神経調節デバイス市場規模：地域別 - 南北アメリカの神経調節デバイス市場規模 アメリカの神経調節デバイス市場規模 カナダの神経調節デバイス市場規模 ブラジルの神経調節デバイス市場規模 ... - アジア太平洋の神経調節デバイス市場規模 日本の神経調節デバイス市場規模 中国の神経調節デバイス市場規模 インドの神経調節デバイス市場規模 韓国の神経調節デバイス市場規模 台湾の神経調節デバイス市場規模 ... - ヨーロッパ/中東/アフリカの神経調節デバイス市場規模 イギリスの神経調節デバイス市場規模 ドイツの神経調節デバイス市場規模 フランスの神経調節デバイス市場規模 ロシアの神経調節デバイス市場規模 ... - その他地域の神経調節デバイス市場規模 ・競争状況 ・企業情報 |
The Global Neuromodulation Devices Market size was estimated at USD 6,791.22 million in 2021 and expected to reach USD 7,665.26 million in 2022, and is projected to grow at a CAGR 13.12% to reach USD 14,233.08 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Neuromodulation Devices to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product Type, the market was studied across Deep Brain Stimulators, Sacral Nerve Stimulators, Spinal Cord Stimulators, Transcranial Magnetic Stimulators, and Vagus Nerve Stimulators.
Based on Application, the market was studied across Neurological Disorders, Pain Management, and Respiratory Disorders.
Based on End User, the market was studied across Hospitals and Specialty Clinics & Ambulatory Centers.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Neuromodulation Devices market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Neuromodulation Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Neuromodulation Devices Market, including Abbott Laboratories, Aleva Neurotherapeutics SA, Avanos Medical Inc, Axonics Modulation Technologies Inc, B. Braun Melsungen AG, Beijing Pins Medical Co Ltd, Bioness Neuromodulation Ltd., Boston Scientific Corporation, iNano Medical inc., IntraPace Inc, LivaNova PLC, Medtronic PLC, Nevro Corp, SPR Therapeutics LLC, Stimwave Technologies Inc., SunMed LLC, Temena SAS, and Xavant Technology (Pty) Ltd.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Neuromodulation Devices Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Neuromodulation Devices Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Neuromodulation Devices Market?
4. What is the competitive strategic window for opportunities in the Global Neuromodulation Devices Market?
5. What are the technology trends and regulatory frameworks in the Global Neuromodulation Devices Market?
6. What is the market share of the leading vendors in the Global Neuromodulation Devices Market?
7. What modes and strategic moves are considered suitable for entering the Global Neuromodulation Devices Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of neurological disorders and nerve injuries
5.1.1.2. Growing focus on neuromodulation & neurostimulation technologies
5.1.1.3. Expanding applications of neuromodulation
5.1.2. Restraints
5.1.2.1. High cost of neuromodulation procedures
5.1.3. Opportunities
5.1.3.1. Government support for research on neurological disorders
5.1.3.2. Development of novel neuromodulation devices
5.1.4. Challenges
5.1.4.1. Stringent regulatory frameworks and time-consuming approval processes
5.2. Cumulative Impact of COVID-19
6. Neuromodulation Devices Market, by Product Type
6.1. Introduction
6.2. Deep Brain Stimulators
6.3. Sacral Nerve Stimulators
6.4. Spinal Cord Stimulators
6.5. Transcranial Magnetic Stimulators
6.6. Vagus Nerve Stimulators
7. Neuromodulation Devices Market, by Application
7.1. Introduction
7.2. Neurological Disorders
7.3. Pain Management
7.4. Respiratory Disorders
8. Neuromodulation Devices Market, by End User
8.1. Introduction
8.2. Hospitals
8.3. Specialty Clinics & Ambulatory Centers
9. Americas Neuromodulation Devices Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Neuromodulation Devices Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Neuromodulation Devices Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Abbott Laboratories
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Aleva Neurotherapeutics SA
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Avanos Medical Inc
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Axonics Modulation Technologies Inc
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. B. Braun Melsungen AG
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Beijing Pins Medical Co Ltd
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Bioness Neuromodulation Ltd.
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Boston Scientific Corporation
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. iNano Medical inc.
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. IntraPace Inc
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. LivaNova PLC
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Medtronic PLC
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Nevro Corp
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. SPR Therapeutics LLC
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Stimwave Technologies Inc.
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. SunMed LLC
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Temena SAS
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Xavant Technology (Pty) Ltd
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing